Ocaliva and Hernia - a phase IV clinical study of FDA data

Summary:

Hernia is reported as a side effect among people who take Ocaliva (obeticholic acid), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Wellbutrin, and have Biliary cirrhosis.

The phase IV clinical study analyzes which people have Hernia when taking Ocaliva. It is created by eHealthMe based on reports of 6,917 people who have side effects when taking Ocaliva from the FDA, and is updated regularly.

What is Ocaliva?

Ocaliva has active ingredients of obeticholic acid. eHealthMe is studying from 6,919 Ocaliva users. Check the latest studies of Ocaliva.

What is Hernia?

Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle) is found to be associated with 1,307 drugs and 1,497 conditions by eHealthMe. Check the latest studies of Hernia.

On Jul, 14, 2026

6,917 people reported to have side effects when taking Ocaliva.
Among them, 11 people (0.16%) have Hernia.

Among these 11 people:

How long have people been on Ocaliva when they have Hernia? *

What is the gender of people who have Hernia when taking Ocaliva? *

female: 85.71 %
male: 14.29 %

What is the age of people who have Hernia when taking Ocaliva? *

What are other drugs people take besides Ocaliva? *

What are other side effects people have besides Hernia? *

Itching: 4 people, 36.36%
Gastric Ulcer (stomach ulcer): 2 people, 18.18%
Sepsis (a severe blood infection that can lead to organ failure and death): 1 person, 9.09%
Hepatic Failure (liver failure): 1 person, 9.09%
Confusion: 1 person, 9.09%
Dehydration (dryness resulting from the removal of water): 1 person, 9.09%
Disease Progression: 1 person, 9.09%
Dizziness: 1 person, 9.09%
Feeling Abnormal: 1 person, 9.09%
Gastritis (inflammation of stomach): 1 person, 9.09%

What are the existing conditions these people have? *

Biliary Cirrhosis (biliary cirrhosis occurs due to obstruction to the flow of bile through bile ducts either within the liver or outside the liver): 2 people, 18.18%
Hypersensitivity: 1 person, 9.09%
High Blood Cholesterol: 1 person, 9.09%
Biliary Cirrhosis Primary (primary biliary cirrhosis (pbc) is a long-term liver disease that damages the small bile ducts in the liver. the build-up of bile damages the liver): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Ocaliva and have Hernia?

- Check whether Hernia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ocaliva:

Ocaliva (6,919 reports)

Hernia treatments and more:

Hernia (31,430 reports)

Browse all side effects of Ocaliva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hernia:

Hernia (1,307 drugs)

Browse all the conditions that are associated with Hernia:

Hernia (1,497 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on obeticholic acid (the active ingredients of Ocaliva) and Ocaliva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.